D. Zhong

发表

Salinomycin induces cell death with autophagy through activation of endoplasmic reticulum stress in human cancer cells

S. Singhal, L. Su, Tianliang Li, 2013, Autophagy.

[Advances of LKB1-AMPK-mTOR Signaling Pathway in Tumor].

Lin-lin Sun, D. Zhong, Xia Zhang, 2011, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

Original Article Efficacy and safety of rituximab combined with chemotherapy in the treatment of diffuse large B-cell lymphoma: a meta-analysis

D. Zhong, Y. Shao, F. Meng, 2015 .

Efficacy and safety of rituximab combined with chemotherapy in the treatment of diffuse large B-cell lymphoma: a meta-analysis.

D. Zhong, Y. Shao, F. Meng, 2015, International journal of clinical and experimental medicine.

Salermide up-regulates death receptor 5 expression through the ATF4-ATF3-CHOP axis and leads to apoptosis in human cancer cells

S. Singhal, L. Su, N. Zhong, 2012, Journal of cellular and molecular medicine.

Comparing the adverse effects of platinum in combination with etoposide or irinotecan in previously untreated small‐cell lung cancer patients with extensive disease: A network meta‐analyses

D. Zhong, Lingxiao Chen, Yujie Chen, 2017, Thoracic cancer.

血清碳酸酐酶Ⅸ检测对肺癌的诊断意义

Lin-lin Sun, Q. Wang, D. Zhong, 2015, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

Significant decrease of ADP release rate underlies the potent activity of dimethylenastron to inhibit mitotic kinesin Eg5 and cancer cell proliferation.

Lin-lin Sun, Haiyang Yu, D. Zhong, 2014, Biochemical and biophysical research communications.

[Immunotherapy in Epidermal Growth Factor Receptor-mutant  Non-small Cell Lung Cancer].

D. Zhong, Xin Wang, 2019, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

[Advanced Research on Non-small Cell Lung Cancer with De Novo T790M Mutation].

D. Zhong, Xin Wang, 2019, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

[Systematic review of the relationship between family history of lung cancer and lung cancer risk].

Qinghua Zhou, D. Zhong, Hongyu Liu, 2010, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

EF24, a novel curcumin analog, disrupts the microtubule cytoskeleton and inhibits HIF-1

J. Snyder, P. Giannakakou, D. Liotta, 2008, Cell cycle.

免疫组化法检测NSCLC患者EGFR突变的相关研究

D. Zhong, Q. Ma, Chang Liu, 2015, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

Lonafarnib Is a Potential Inhibitor for Neovascularization

Lin-lin Sun, J. Qin, D. Zhong, 2015, PloS one.

表皮生长因子受体突变细胞系H1650耐药机制探讨

Lin-lin Sun, D. Zhong, Juan Zhao, 2012, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

Routine-Dose and High-Dose Icotinib in Patients with Advanced Non–Small Cell Lung Cancer Harboring EGFR Exon 21-L858R Mutation: the Randomized, Phase II, INCREASE Trial

W. Su, Li Zhang, D. Zhong, 2020, Clinical Cancer Research.

免疫组化法检测非小细胞肺癌EGFR突变的进展

D. Zhong, Chang Liu, Dongbo Xu, 2014, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

EGFR-TKI原发性耐药的分子机制及其进展——附2例病例分析

D. Zhong, F. Meng, Q. Ma, 2019, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

特异性抗体免疫组化法检测EGFR突变价值的meta分析

D. Zhong, Q. Ma, Chang Liu, 2014, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

免疫组化染色评分对EGFR突变检测的影响

D. Zhong, Chang Liu, Xin Feng, 2015, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

LKB1 is necessary for Akt-mediated phosphorylation of proapoptotic proteins.

F. Khuri, Shi-Yong Sun, P. Vertino, 2008, Cancer research.

[Curative Effect of Aprepitant Preventing CINV].

D. Zhong, Y. Shao, Tao Yu, 2018, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

胸腔积液沉淀物在恶性胸腔积液诊断中的价值

Qian Wang, D. Zhong, Qian Wang, 2015, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

Retrospective study of EGFR‐mutant lung adenocarcinoma with bone metastatic clinical features

D. Zhong, Ting Gong, Q. Ma, 2022, Cancer reports.

胸腔积液沉淀物在恶性胸腔积液诊断中的临床应用价值

D. Zhong, Xintong Wang, Y. Shao, 2017, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

Glutamine-β-cyclodextrin for targeted doxorubicin delivery to triple-negative breast cancer tumors via the transporter ASCT2.

Zhiyan Zhu, D. Zhong, Shuqing Wang, 2019, Journal of materials chemistry. B.

Autopsy case report

D. Zhong, Zhe Chen, Baoyuan Chen, 2008 .

Fosaprepitant versus aprepitant in the prevention of chemotherapy-induced nausea and vomiting in patients receiving cisplatin-based chemotherapy: a multicenter, randomized, double-blind, double-simulated, positive-controlled phase III trial

Jingdong He, K. Nan, Jian-hua Chang, 2020, Annals of translational medicine.

小细胞肺癌免疫治疗研究进展

D. Zhong, Tao Yu, 2018, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

Potential predictive value of comutant LRP1B and FAT for immune response in non-small cell lung cancer

D. Zhong, Fang Hao, Q. Ma, 2022, Translational oncology.

The role of brain metastases in patients with pulmonary adenocarcinoma: a retrospective study.

D. Zhong, Xiaoqing Li, Q. Qin, 2021, Annals of palliative medicine.

DNA损伤修复系统与肺癌的药物治疗

D. Zhong, F. Meng, Linlin Zhang, 2022, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

[Immune Checkpoint Inhibitors Related Diabetes Mellitus:  A Report of 2 Cases and Literature Review].

D. Zhong, Linlin Zhang, Yao-yao Ren, 2022, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

LKB1 promotes cell survival by modulating TIF-IA-mediated pre-ribosomal RNA synthesis under uridine downregulated conditions

A. Marcus, F. Khuri, H. Fu, 2015, Oncotarget.

Sox7 Is an Independent Checkpoint for β-Catenin Function in Prostate and Colon Epithelial Cells

C. Moreno, V. Yang, W. Zhou, 2008, Molecular Cancer Research.

Inhibition of IGF1R enhances 2-deoxyglucose in the treatment of non-small cell lung cancer.

A. Marcus, F. Khuri, Shi-Yong Sun, 2018, Lung cancer.

[Value of Detection of CAIX in the Pleural Effusion and Its Sediment in the Diagnosis of Lung Cancer].

D. Zhong, Qian Wang, X. Wang, 2015, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

Toripalimab Plus Chemotherapy for Patients With Treatment-Naive Advanced Non–Small-Cell Lung Cancer: A Multicenter Randomized Phase III Trial (CHOICE-01)

Ying Cheng, P. Keegan, Baolan Li, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Next-generation sequencing of homologous recombination genes could predict efficacy of platinum-based chemotherapy in non-small cell lung cancer

D. Zhong, F. Meng, Linlin Zhang, 2022, Frontiers in Oncology.

TP53 Mutation Mapping in Advanced Non-Small Cell Lung Cancer: A Real-World Retrospective Cohort Study

D. Zhong, Fang Hao, Liyan Gu, 2022, Current oncology.

Treatment Pattern and Overall Survival of Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer: A Multicentric Real-World Study in China (CTONG1506)

Yi-long Wu, P. Yu, D. Zhong, 2020 .

Safety and efficacy of administering reduced doses of pegylated recombinant human granulocyte‐colony stimulating factors in patients treated with cisplatin and etoposide for small cell carcinoma: A retrospective study

D. Zhong, F. Meng, Chang Liu, 2021, Thoracic cancer.

A case report of steroid-refractory bullous pemphigoid induced by immune checkpoint inhibitor therapy

D. Zhong, Junyang Zhang, Linlin Zhang, 2023, Frontiers in Immunology.

Death receptor 5 and cellular FLICE-inhibitory protein regulate pemetrexed-induced apoptosis in human lung cancer cells.

S. Singhal, L. Su, N. Zhong, 2011, European journal of cancer.

High kinesin family member 18A expression correlates with poor prognosis in primary lung adenocarcinoma

Lin-lin Sun, D. Zhong, Xiaoqing Li, 2019, Thoracic cancer.

Identification of a DNA damage repair gene‐related signature for lung squamous cell carcinoma prognosis

Changli Wang, D. Zhong, Ting Gong, 2022, Thoracic cancer.

2-Deoxyglucose induces Akt phosphorylation via a mechanism independent of LKB1/AMP-activated protein kinase signaling activation or glycolysis inhibition

A. Marcus, F. Khuri, Shi-Yong Sun, 2008, Molecular Cancer Therapeutics.

Difficult differential diagnosis of bladder pedicled masses about metastasis from non-small cell lung cancer: A case report

D. Zhong, Xiaoqing Li, Linlin Zhang, 2021, Cancer biology & therapy.

CDK4/6 inhibitor palbociclib overcomes acquired resistance to third‐generation EGFR inhibitor osimertinib in non‐small cell lung cancer (NSCLC)

Lin-lin Sun, D. Zhong, Xiaoqing Li, 2020, Thoracic cancer.

Molecular mechanism of acquired drug resistance in the EGFR‐TKI resistant cell line HCC827‐TR

D. Zhong, Ting Gong, Tao Yu, 2020, Thoracic cancer.

晚期非小细胞肺癌HER2基因突变靶向治疗进展

D. Zhong, 殿胜 Diansheng 钟 ZHONG, L. Kong, 2020, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

Targeting the EMT transcription factor Snail overcomes resistance to osimertinib in EGFR‐mutant non‐small cell lung cancer

Lin-lin Sun, D. Zhong, Xiaoqing Li, 2021, Thoracic cancer.

Giant solitary fibrous tumor of the lung: A case report

Lin-lin Sun, D. Zhong, Dongbo Xu, 2014, Thoracic cancer.

EGFR-TKIs与化疗比较一线治疗非小细胞肺癌疗效的meta分析

D. Zhong, Linlin Zhang, Yan Wang, 2015, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

2-Deoxyglucose Suppresses ERK Phosphorylation in LKB1 and Ras Wild-Type Non-Small Cell Lung Cancer Cells

Lin-lin Sun, H. Fu, Wei Zhou, 2016, PloS one.

A. Marcus, Wei Zhou, D. Zhong, 2012, The Journal of Biological Chemistry.

A. Marcus, Wei Zhou, D. Zhong, 2012 .

Liver kinase B1/adenosine monophosphate-activated protein kinase signaling axis induces p21/WAF1 expression in a p53-dependent manner.

Lin-lin Sun, D. Zhong, Q. Ma, 2018, Oncology letters.

Retrospective study of the efficacy and toxicity of lobaplatin‐etoposide chemotherapy in small cell lung cancer

D. Zhong, Tao Yu, F. Meng, 2019, Thoracic cancer.

Homozygous deletion of SMAD4 in breast cancer cell lines and invasive ductal carcinomas

A. Nassar, C. Colpaert, W. Zhou, 2006, Cancer biology & therapy.

Allelic imbalances of chromosomes 8p and 18q and their roles in distant relapse of early stage, node-negative breast cancer

C. Colpaert, L. Dirix, W. Zhou, 2005, Breast Cancer Research.

LKB1信号通路在非小细胞肺癌相关靶向治疗中的研究进展

D. Zhong, Ruili Han, Jing Wang, 2012, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

LKB1 mutation in large cell carcinoma of the lung.

Shi-Yong Sun, P. Vertino, D. Zhong, 2006, Lung cancer.

Concurrent epidermal growth factor receptor T790M secondary mutation and epithelial‐mesenchymal transition in a lung adenocarcinoma patient with EGFR‐TKI drug resistance

D. Zhong, Jun Chen, Tao Shi, 2017, Thoracic cancer.

Liver kinase B 1 / adenosine monophosphate ‐ activated protein kinase signaling axis induces p 21 / WAF 1 expression in a p 53 ‐ dependent manner

Lin-lin Sun, D. Zhong, Jing Wang, 2018 .

EGFR exon 19‐deletion aberrantly regulate ERCC1 expression that may partly impaired DNA damage repair ability in non‐small cell lung cancer

D. Zhong, Lili Guo, F. Meng, 2019, Thoracic cancer.

EGFR gene-mutation status correlated with therapeutic decision making in lung adenocarcinoma

D. Zhong, Q. Ma, Yibing Yao, 2015, OncoTargets and therapy.

The Glycolytic Inhibitor 2-Deoxyglucose Activates Multiple Prosurvival Pathways through IGF1R*

Y. Zong, F. Khuri, Shi-Yong Sun, 2009, The Journal of Biological Chemistry.

Chemotherapy-induced thrombocytopenia: literature review

D. Zhong, Linlin Zhang, Ai-Bao Gao, 2023, Discover Oncology.

Lung adenocarcinoma associated with cystic airspaces

X. Yang, D. Zhong, Dong Li, 2022, Chronic diseases and translational medicine.

Safety and efficacy of aprepitant as mono and combination therapy for the prevention of emetogenic chemotherapy-induced nausea and vomiting: post-marketing surveillance in China.

He-long Zhang, Wei Li, Dong Wang, 2020, Chinese clinical oncology.

The chalcone 2′‐hydroxy‐4′,5′‐dimethoxychalcone activates death receptor 5 pathway and leads to apoptosis in human nonsmall cell lung cancer cells

Lina Yang, L. Su, Lijia Xu, 2013, IUBMB life.

Manual lymphatic drainage for breast cancer‐related lymphoedema

D. Zhong, Y. Shao, 2017, European journal of cancer care.

A multicenter, randomized, double-blind, placebo-controlled, phase 3 trial of olanzapine plus triple antiemetic regimen for the prevention of multiday highly emetogenic chemotherapy-induced nausea and vomiting (OFFER study)

D. Zhong, Yanqiu Zhao, Yun-peng Yang, 2022, EClinicalMedicine.

Antiangiogenic Agents Combined with Chemotherapy in the First-Line Treatment of Advanced Non-Small-Cell Lung Cancer: Overall and Histology Subgroup-Specific Meta-Analysis

D. Zhong, Linlin Zhang, Yan Wang, 2014, Oncology Research and Treatment.

Central nervous system efficacy of rezivertinib (BPI-7711) in advanced NSCLC patients with EGFR T790M mutation: A pooled analysis of two clinical studies.

T. Wang, D. Zhong, Yanqiu Zhao, 2023, Lung cancer.

Ef ﬁ cacy and Safety of Rezivertinib (BPI-7711) in Patients With Locally Advanced or Metastatic/ Recurrent EGFR T790M-Mutated NSCLC: A Phase 2b Study

T. Wang, D. Zhong, Yanqiu Zhao, 2022 .

[Advances of human epididymis protein 4 in lung cancer].

D. Zhong, Qian Wang, Q. Ma, 2015, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

Safety and effectiveness of apatinib in patients with previously treated metastatic gastric cancer: a sub-analysis from the real-world study of apatinib for gastric cancer treatment (AHEAD-G202).

Qingshan Li, Ping Yang, D. Zhong, 2020, American journal of cancer research.

An open label, multicenter, noninterventional study of apatinib in advanced gastric cancer patients (AHEAD-G202)

Qingshan Li, Ping Yang, D. Zhong, 2020, Therapeutic advances in medical oncology.

非小细胞肺癌EGFR和ALK基因双突变研究进展

D. Zhong, Xin Wang, 2018, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

STRN-ALK Fusion in Lung Adenocarcinoma with Brain Metastasis Responded Well to Ensartinib: A Case Report

D. Zhong, F. Meng, Linlin Zhang, 2022, Current oncology.

[A case report of anterior-mediastinal bulky lesion].

D. Zhong, Xiaoli Wang, Ruili Han, 2012, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

PD-L1 deficiency sensitizes tumor cells to DNA-PK inhibition and enhances cGAS-STING activation.

Jiaming Song, M. Hung, Lin-lin Sun, 2022, American journal of cancer research.

Efficacy, safety and pharmacokinetics of Unecritinib (TQ-B3101) for patients with ROS1 positive advanced non-small cell lung cancer: a Phase I/II Trial

Shun Lu, Yang Zhang, D. Zhong, 2023, Signal transduction and targeted therapy.

[To promote the clinical application of endobronchial ultrasound-guided transbronchial needle aspiration in China].

Qinghua Zhou, D. Zhong, 2010, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

Abstract CT034: Phase II study of SCC244 in NSCLC patients harboring MET exon 14 skipping (METex14) mutations (GLORY study)

K. Goto, Jialei Wang, D. Zhong, 2022, Cancer Research.

Case Report: Dramatic Response to Crizotinib in a Patient With Non-Small Cell Lung Cancer Positive for a Novel ARL1-MET Fusion

D. Zhong, Q. Ma, L. Kong, 2022, Frontiers in Oncology.

Prolonged usage of fosaprepitant for prevention of delayed chemotherapy-induced nausea and vomiting(CINV) in patients receiving highly emetogenic chemotherapy

D. Zhong, F. Meng, Linlin Zhang, 2023, BMC Cancer.

免疫组化法检测EML4-ALK融合突变价值的meta分析

D. Zhong, Lu Cai, Chang Liu, 2016, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

EGFR p.V774M/p.L833V compound mutations in lung adenocarcinoma responded well to almonertinib: a case report

D. Zhong, F. Meng, Linlin Zhang, 2023, Frontiers in Oncology.

Selective degradation of the p53‐R175H oncogenic hotspot mutant by an RNA aptamer‐based PROTAC

D. Zhong, Min Liu, Jun Zhou, 2023, Clinical and translational medicine.

加速肺康复外科，需要精准治疗吗？

D. Zhong, Y. Shao, 伦旭 Lunxu 刘 LIU, 2017, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

Study of anlotinib combined with icotinib as the first-line treatment in non-small cell lung cancer (NSCLC) patients harboring activating EGFR mutations (ALTER-L004).

D. Zhong, Y. Shang, Dingzhi Huang, 2020 .

Oral fluoropyrimidine versus intravenous 5‐fluorouracil for the treatment of advanced gastric and colorectal cancer: Meta‐analysis

D. Zhong, F. Meng, Linlin Zhang, 2018, Journal of gastroenterology and hepatology.

Anlotinib plus icotinib as a potential treatment option for EGFR-mutated advanced non-squamous non-small cell lung cancer with concurrent mutations: final analysis of the prospective phase 2, multicenter ALTER-L004 study

D. Zhong, Yan Zhang, Y. Shang, 2023, Molecular Cancer.

肺癌家族聚集性的系统评价

Qinghua Zhou, D. Zhong, Hongyu Liu, 2010, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

LKB1-AMPK-mTOR信号传导通路在肿瘤中的研究进展

Lin-lin Sun, D. Zhong, Xia Zhang, 2011, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

BRAF突变型非小细胞肺癌免疫检查点抑制剂治疗进展

D. Zhong, Xia Liu, 2019, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

Galectin-9 blockade synergizes with ATM inhibition to induce potent anti-tumor immunity

Jiaming Song, M. Hung, Lin-lin Sun, 2023, International journal of biological sciences.

一线化疗方案治疗广泛期小细胞肺癌的网状meta分析

D. Zhong, Lingxiao Chen, Yujie Chen, 2016, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

CDK4/6抑制剂在非小细胞肺癌治疗中的研究进展

D. Zhong, Q. Qin, Yao-yao Ren, 2020, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

MA13.08 CHOICE-01: A Phase 3 Study of Toripalimab Versus Placebo in Combination With First-Line Chemotherapy for Advanced NSCLC

Y. Wang, P. Keegan, D. Zhong, 2021, Journal of Thoracic Oncology.

晚期非小细胞肺癌BRAF突变靶向治疗进展

D. Zhong, Xia Liu, 2018, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

The protein kinase C (PKC) inhibitors combined with chemotherapy in the treatment of advanced non-small cell lung cancer: meta-analysis of randomized controlled trials

Y. Zhang, D. Zhong, D. Zhong, 2015, Clinical and Translational Oncology.

以肺性肥大性骨关节病为首发表现的肺癌1例报道

D. Zhong, Linjuan Lian, Song Wu, 2010, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

The chalcone 2′‐hydroxy‐4′,5′‐dimethoxychalcone activates death receptor 5 pathway and leads to apoptosis in human nonsmall cell lung cancer cells

Lina Yang, L. Su, Lijia Xu, 2013, IUBMB life.